Medicare's policy on carotid stents limited use to hospitals meeting quality guidelines yet did not hurt disadvantaged

Health Affairs

Volumn 30, Issue 2, 2011, Pages 312-321

  Groeneveld, Peter W ^a   Epstein, Andrew J ^a   Yang, Feifei ^b   Yang, Lin ^b   Polsky, Daniel ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CAROTID ARTERY STENTING; EXTRACORPOREAL CIRCULATION; HEALTH CARE POLICY; HEALTH CARE QUALITY; HOSPITAL; HUMAN; MEDICAL TECHNOLOGY; MEDICARE; PATIENT REFERRAL; POPULATION RESEARCH; PRACTICE GUIDELINE; RURAL POPULATION; SENSITIVITY ANALYSIS; UNITED STATES;

CAROTID STENOSIS; DIFFUSION OF INNOVATION; FEMALE; GUIDELINE ADHERENCE; HEALTH POLICY; HEALTH SERVICES ACCESSIBILITY; HOSPITALS; HUMANS; MALE; MEDICARE; STENTS; UNITED STATES; VULNERABLE POPULATIONS;

EID: 79955581635     PISSN: 02782715     EISSN: 15445208     Source Type: Journal    
DOI: 10.1377/hlthaff.2010.0320     Document Type: Article

References (37)

1. US Food and Drug Administration. ACCULINK carotid stent system/RX ACCULINK carotid stent system-P040012 [Internet]. Silver Spring (MD): FDA; 2009 Jul 8 [cited 2010 Dec 27]. Available from: http://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/DeviceApprovalsandClearances/Recently-ApprovedDevices/ucm080874.htm.
2. Centers for Medicare and Medicaid Services. Decision memo for carotid arterial stenting (CAG-00085R) [Internet]. Baltimore (MD): CMS; 2010 Jan 14 [cited 2011 Jan 11]. Available from: http://www.cms.gov/mcd/viewdecisionmemo.asp?from2=viewdecisionmemo.asp&id=157&.
3. Centers for Medicare and Medicaid Services. National coverage determinations with data collection as a condition of coverage: coverage with evidence development [Internet]. Baltimore (MD): CMS; 2006 Jul 12 [cited 2010 Feb 16]. Available from: https://www.cms.hhs.gov/mcd/ncpc_view_document.asp?id=8.
4. McClellan MB, Tunis SR. Medicare coverage of ICDs. N Engl J Med. 2005;352(3):222-4.
5. Neumann PJ, Kamae MS, Palmer JA. Medicare's national coverage decisions for technologies, 1999-2007. Health Aff (Millwood). 2008;27(6): 1620-31.
6. Tunis SR, Carino TV, Williams RD 2nd, Bach PB. Federal initiatives to support rapid learning about new technologies. Health Aff (Millwood). 2007;26(2):w140-9.
7. Neumann PJ, Tunis SR. Medicare and medical technology-the growing demand for relevant outcomes. N Engl J Med. 2010;362(5):377-9.
8. Tunis SR, Pearson SD. Coverage options for promising technologies: Medicare's "coverage with evidence development." Health Aff (Millwood). 2006;25(5):1218-30.
9. Beohar N, Davidson CJ, Kip KE, Goodreau L, Vlachos HA, Meyers SN, et al. Outcomes and complications associated with off-label and untested use of drug-eluting stents. JAMA. 2007;297(18):1992-2000.
10. Wennberg DE, Lucas FL, Birkmeyer JD, Bredenberg CE, Fisher ES. Variation in carotid endarterectomy mortality in the Medicare population: trial hospitals, volume, and patient characteristics. JAMA. 1998;279(16):1278-81.
11. Chassin MR, Brook RH, Park RE, Keesey J, Fink A, Kosecoff J, et al. Variations in the use of medical and surgical services by the Medicare population. N Engl J Med. 1986; 314(5):285-90.
12. Steinberg EP, Sisk JE, Locke KE. X-ray, CT, and magnetic resonance imagers-diffusion patterns and policy issues. N Engl J Med. 1985; 313(14):859-64.
13. Groeneveld PW, Laufer SB, Garber AM. Technology diffusion, hospital variation, and racial disparities among elderly Medicare beneficiaries: 1989-2000. Med Care. 2005; 43(4):320-9.
14. Goodney PP, Travis LL, Malenka D, Bronner KK, Lucas FL, Cronenwett JL, et al. Regional variation in carotid artery stenting and endarterectomy in the Medicare population. Circ Cardiovasc Qual Outcomes. 2010;3(1):15-24.
15. Groeneveld PW, Yang L, Greenhut A, Yang F. Comparative effectiveness of carotid arterial stenting versus end-arterectomy. J Vasc Surg. 2009; 50(5):1040-8.
16. Werner RM, Goldman LE, Dudley RA. Comparison of change in quality of care between safety-net and non-safety-net hospitals. JAMA. 2008; 299(18):2180-7.
17. Centers for Medicare and Medicaid Services. Carotid artery stenting facilities [Internet]. Baltimore (MD): CMS; 2009 [cited 2009 October 13]. Available from: http://www.cms.hhs.gov/MedicareApprovedfacilitie/CASF/List.asp.
18. Dartmouth Institute for Health Policy and Clinical Practice. Dartmouth atlas of health care-appendix on the geography of health care in the United States [Internet]. Lebanon (NH): Trustees of Dartmouth College; 2008 [updated 2010 Apr 15; cited 2011 Jan 11]. Available from: http://www.dartmouthatlas.org/downloads/methods/geogappdx.pdf.
19. To access the Appendix, click on the Appendix link in the box to the right of the article online.
20. Yadav JS, Wholey MH, Kuntz RE, Fayad P, Katzen BT, Mishkel GJ, et al. Protected carotidartery stenting versus endarterectomy in high-risk patients. N Engl J Med. 2004;351(15):1493-501.
21. CaRESS Steering Committee. Carotid revascularization using endarterectomy or stenting systems (CaRESS): phase I clinical trial. J Endovasc Ther. 2003;10(6):1021-30.
22. Hobson RW 2nd, Howard VJ, Roubin GS, Brott TG, Ferguson RD, Popma JJ, et al. Carotid artery stenting is associated with increased complications in octogenarians: 30-day stroke and death rates in the CREST lead-in phase. J Vasc Surg. 2004;40(6):1106-11.
23. Diagnosis codes and diagnosis-related groups (DRGs) were based on the International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM).
24. Centers for Medicare and Medicaid Services. Medicare program; changes to the hospital inpatient prospective payment systems and fiscal year 2007 rates; fiscal year 2007 occupational mix adjustment to wage index; Health Care Infrastructure Improvement Program; selection criteria of loan program for qualifying hospitals engaged in cancer-related health care and forgiveness of indebtedness; and exclusion of vendor purchases made under the Competitive Acquisition Program (CAP) for outpatient drugs and biologicals under Part B for the purpose of calculating the average sales price (ASP). Fed Regist. 2006;71(160):47942-4.
25. Teplensky JD, Pauly MV, Kimberly JR, Hillman AL, Schwartz JS. Hospital adoption of medical technology: an empirical test of alternative models. Health Serv Res. 1995; 30(3):437-65.
26. Mas JL, Chatellier G, Beyssen B, Branchereau A, Moulin T, Becquemin JP, et al. Endarterectomy versus stenting in patients with symptomatic severe carotid stenosis. N Engl J Med. 2006;355(16): 1660-71.
27. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005;352(3):225-37.
28. Oddone EZ, Horner RD, Monger ME, Matchar DB. Racial variations in the rates of carotid angiography and endarterectomy in patients with stroke and transient ischemic attack. Arch Intern Med. 1993;153(24): 2781-6.
29. Bach PB. Racial disparities and site of care. Ethn Dis. 2005; 15(2 Suppl 2):S31-3.
30. Groeneveld PW, Heidenreich PA, Garber AM. Trends in implantable cardioverter-defibrillator racial disparity: the importance of geography. J Am Coll Cardiol. 2005;45(1):72-8.
31. Pearson SD, Miller FG, Emanuel EJ. Medicare's requirement for research participation as a condition of coverage: is it ethical? JAMA. 2006; 296(8):988-91.
32. Ederle J, Dobson J, Featherstone RL, Bonati LH, van der Worp HB, de Borst GJ, et al. Carotid artery stenting compared with endarterectomy in patients with symptomatic carotid stenosis (International Carotid Stenting Study): an interim analysis of a randomised controlled trial. Lancet. 2010;375(9719):985-97.
33. Fuchs VR. Economics, values, and health care reform. Am Econ Rev. 1996;86(1):1-24.
34. Pauly MV. What if technology never stops improving? Medicare's future under continuous cost increases. Spec Law Dig Health Care Law. 2004;(308):9-26.
35. Garber AM. Evidence-based coverage policy. Health Aff (Millwood). 2001;20(5):62-82.
36. Weingart SN. Acquiring advanced technology: decision-making strategies at twelve medical centers. Int J Technol Assess Health Care. 1993; 9(4):530-8.
37. Gelijns A, Rosenberg N. The dynamics of technological change in medicine. Health Aff (Millwood). 1994;13(3):28-46.